NCT07337564
- Conditions
- Pyoderma, Pyoderma Gangrenosum, Skin Diseases, +3 more
- Locations
-
- Dermatology Hospital Affiliated to Shandong First Medical University Jinan, Shandong, China
Clinical trial condition
Pyoderma
Explore clinical trials studying Pyoderma. Study availability and eligibility vary by location and protocol.
15 public trials
2 recruiting studies
Pyoderma trial results
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
NCT06624670
- Conditions
- Pyoderma, Pyoderma Gangrenosum, Skin Diseases, +3 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Medical Dermatology Specialists Phoenix Phoenix, Arizona, United States
- University of California Irvine Irvine, California, United States
- University of Miami Miami, Florida, United States
Not yet recruiting
Emerging Indications for Hyperbaric Oxygen Treatment
NCT07240649
- Conditions
- Acute COVID-19, Anastomosis, Leaking, Arterial Occlusive Diseases, +137 more
- Locations
-
Not specified
Not yet recruiting
Topical Ruxolitinib in the Treatment of Adults With Pyoderma Gangrenosum
NCT07783412
- Conditions
- Pyoderma, Pyoderma Gangrenosum, Skin Diseases, +4 more
- Locations
-
Not specified
Not yet recruiting
A Study to Evaluate SHR-1139 Injection in Patients With Pyoderma Gangrenosum
NCT07444684
- Conditions
- Pyoderma, Pyoderma Gangrenosum, Skin Diseases, +3 more
- Locations
-
- Shandong First Medical University Affiliated Dermatology Hospital Jinan, Shandong, China
NCT04750213
- Conditions
- Pyoderma, Pyoderma Gangrenosum, Skin Diseases, +3 more
- Locations
-
- NHO Nagoya Medical Center /ID# 246013 Nagoya, Aichi-ken, Japan
- Nagoya City University Hospital /ID# 233778 Nagoya, Aichi-ken, Japan
- Akita University Hospital /ID# 242706 Akita, Japan
- Kyushu University Hospital /ID# 247492 Fukuoka, Japan
NCT01965613
- Conditions
- Pyoderma, Pyoderma Gangrenosum, Skin Diseases, +3 more
- Locations
-
- XBiotech Investigative Site Tallahassee, Florida, United States
Completed
An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum
NCT03137160
- Conditions
- Pyoderma, Pyoderma Gangrenosum, Skin Diseases, +3 more
- Locations
-
- The Ohio State University Dermatology Gahanna, Ohio, United States
NCT03971643
- Conditions
- Pyoderma, Pyoderma Gangrenosum, Skin Diseases, +3 more
- Locations
-
- InflaRx Site #07 Sacramento, California, United States
- InflaRx Site #08 Miami, Florida, United States
- InflaRx Site #03 Tampa, Florida, United States
- InflaRx Site #10 St Louis, Missouri, United States
NCT02733094
- Conditions
- Pyoderma, Pyoderma Gangrenosum, Skin Diseases, +3 more
- Locations
-
- Technical University of Munich Munich, Germany